Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program

Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response....

Descripción completa

Detalles Bibliográficos
Autores principales: Eckhardt, Benjamin J, Scherer, Matthew, Winkelstein, Emily, Marks, Kristen, Edlin, Brian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887278/
https://www.ncbi.nlm.nih.gov/pubmed/29644246
http://dx.doi.org/10.1093/ofid/ofy048
_version_ 1783312265204727808
author Eckhardt, Benjamin J
Scherer, Matthew
Winkelstein, Emily
Marks, Kristen
Edlin, Brian R
author_facet Eckhardt, Benjamin J
Scherer, Matthew
Winkelstein, Emily
Marks, Kristen
Edlin, Brian R
author_sort Eckhardt, Benjamin J
collection PubMed
description Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.
format Online
Article
Text
id pubmed-5887278
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58872782018-04-11 Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program Eckhardt, Benjamin J Scherer, Matthew Winkelstein, Emily Marks, Kristen Edlin, Brian R Open Forum Infect Dis Brief Report Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment. Oxford University Press 2018-03-06 /pmc/articles/PMC5887278/ /pubmed/29644246 http://dx.doi.org/10.1093/ofid/ofy048 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Eckhardt, Benjamin J
Scherer, Matthew
Winkelstein, Emily
Marks, Kristen
Edlin, Brian R
Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title_full Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title_fullStr Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title_full_unstemmed Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title_short Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
title_sort hepatitis c treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887278/
https://www.ncbi.nlm.nih.gov/pubmed/29644246
http://dx.doi.org/10.1093/ofid/ofy048
work_keys_str_mv AT eckhardtbenjaminj hepatitisctreatmentoutcomesforpeoplewhoinjectdrugstreatedinanaccessiblecareprogramlocatedatasyringeserviceprogram
AT scherermatthew hepatitisctreatmentoutcomesforpeoplewhoinjectdrugstreatedinanaccessiblecareprogramlocatedatasyringeserviceprogram
AT winkelsteinemily hepatitisctreatmentoutcomesforpeoplewhoinjectdrugstreatedinanaccessiblecareprogramlocatedatasyringeserviceprogram
AT markskristen hepatitisctreatmentoutcomesforpeoplewhoinjectdrugstreatedinanaccessiblecareprogramlocatedatasyringeserviceprogram
AT edlinbrianr hepatitisctreatmentoutcomesforpeoplewhoinjectdrugstreatedinanaccessiblecareprogramlocatedatasyringeserviceprogram

Ejemplares similares